CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Common Stock Class A Common Stock	Common Stock Class B Common Stock	Additional Paid-In Capital	Accumulated Deficit	Class A Common Stock	Class B Common Stock	Total
Balance at beginning of the period at Dec. 31, 2022	$ 17	$ 3	$ 921,278	$ (595,938)			$ 325,360
Balance at beginning of the period (in shares) at Dec. 31, 2022	174,459,956	26,426,937
Increase (Decrease) in Stockholders' Equity
Net loss				(62,211)			(62,211)
Common stock issued upon exercise of stock options			136				136
Common stock issued upon exercise of stock options (in shares)	124,660
Common stock issued upon vesting of restricted stock units	$ 1						1
Common stock issued upon vesting of restricted stock units (in shares)	5,136,302
Stock-based compensation expense			14,419				14,419
Balance at end of the period at Jun. 30, 2023	$ 18	$ 3	935,833	(658,149)			277,705
Balance at end of the period (in shares) at Jun. 30, 2023	179,720,918	26,426,937
Balance at beginning of the period at Mar. 31, 2023	$ 18	$ 3	925,604	(629,478)			296,147
Balance at beginning of the period (in shares) at Mar. 31, 2023	177,368,499	26,426,937
Increase (Decrease) in Stockholders' Equity
Net loss				(28,671)			(28,671)
Common stock issued upon exercise of stock options			136				136
Common stock issued upon exercise of stock options (in shares)	124,660
Common stock issued upon vesting of restricted stock units (in shares)	2,227,759
Stock-based compensation expense			10,093				10,093
Balance at end of the period at Jun. 30, 2023	$ 18	$ 3	935,833	(658,149)			277,705
Balance at end of the period (in shares) at Jun. 30, 2023	179,720,918	26,426,937
Balance at beginning of the period at Dec. 31, 2023	$ 18	$ 3	949,670	(729,638)			220,053
Balance at beginning of the period (in shares) at Dec. 31, 2023	181,221,794	26,426,937			181,221,794	26,426,937
Increase (Decrease) in Stockholders' Equity
Net loss				(37,467)			(37,467)
Common stock issued upon vesting of restricted stock units	$ 1						1
Common stock issued upon vesting of restricted stock units (in shares)	4,815,903
Stock-based compensation expense			11,693				11,693
Balance at end of the period at Jun. 30, 2024	$ 19	$ 3	961,363	(767,105)			194,280
Balance at end of the period (in shares) at Jun. 30, 2024	186,037,697	26,426,937			186,037,697	26,426,937
Balance at beginning of the period at Mar. 31, 2024	$ 18	$ 3	955,382	(751,399)			204,004
Balance at beginning of the period (in shares) at Mar. 31, 2024	184,214,377	26,426,937
Increase (Decrease) in Stockholders' Equity
Net loss				(15,706)			(15,706)
Common stock issued upon vesting of restricted stock units	$ 1						1
Common stock issued upon vesting of restricted stock units (in shares)	1,823,320
Stock-based compensation expense			5,981				5,981
Balance at end of the period at Jun. 30, 2024	$ 19	$ 3	$ 961,363	$ (767,105)			$ 194,280
Balance at end of the period (in shares) at Jun. 30, 2024	186,037,697	26,426,937			186,037,697	26,426,937